Want to see AU:NC6 full AI Analyst Report?
NC6 Stock Chart & Stats
AU$0.05
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.05
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.04 - AU$0.08
Previous CloseN/A
Volume1.00
Average Volume (3M)138.71K
Market Cap
AU$32.31M
Enterprise ValueAU$18.23M
Total Cash (Recent Filing)AU$274.97K
Total Debt (Recent Filing)AU$250.21K
Price to Earnings (P/E)―
Beta-0.31
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding409,026,920
10 Day Avg. Volume179,263
30 Day Avg. Volume138,709
Financial Highlights & Ratios
PEG Ratio2.33
Price to Book (P/B)34.86
Price to Sales (P/S)0.00
P/FCF Ratio-12.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance-sheet OptionalityLow reported leverage is a durable structural strength: limited debt reduces near-term solvency pressure and preserves management’s optionality to prioritize R&D or strategic partnerships rather than servicing creditors. This supports runway extension while commercialisation progresses.
Strategic Positioning In Sustainable BiomaterialsNanollose’s microbial cellulose focus aligns with long-term structural demand for sustainable textiles and materials. Such a differentiated, bio-based product can create durable competitive advantages in supply chains seeking lower-impact alternatives, supporting multi-quarter commercial opportunities.
Improving Cash-burn TrendAn observable reduction in cash burn is a meaningful fundamental signal: improving FCF trends can extend runway, reduce immediate financing needs, and indicate operational efficiencies or slower investment pacing—each helping the company buy time to commercialise its technology.
Bears Say
Revenue Collapse / Lack Of Commercial TractionA fall to zero reported revenue is a critical structural weakness: it signals minimal commercial adoption or disrupted sales execution. Without recurring revenue, the business cannot scale margins or demonstrate product-market fit, intensifying reliance on financing and hampering long-term viability.
Persistent Losses And Deteriorating MarginsSustained net losses and worsening margins erode the company’s capacity to self-fund growth and impair returns on invested capital. Over multiple quarters, this limits strategic options, increases dilution risk if financed via equity, and challenges achievement of durable competitive economics.
Negative Operating And Free Cash Flow; Funding RiskPersistent negative operating and free cash flow creates an ongoing need for external capital. Dependence on financing exposes the company to funding availability and dilution risk, constrains long-term planning, and can force trade-offs between commercialization investments and survival priorities.
Nanollose Ltd. News
NC6 FAQ
What was Nanollose Ltd.’s price range in the past 12 months?
Nanollose Ltd. lowest share price was AU$0.04 and its highest was AU$0.08 in the past 12 months.
What is Nanollose Ltd.’s market cap?
Nanollose Ltd.’s market cap is AU$32.31M.
When is Nanollose Ltd.’s upcoming earnings report date?
Nanollose Ltd.’s upcoming earnings report date is Aug 31, 2026 which is in 8 days.
How were Nanollose Ltd.’s earnings last quarter?
Nanollose Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
Is Nanollose Ltd. overvalued?
According to Wall Street analysts Nanollose Ltd.’s price is currently Overvalued.
Does Nanollose Ltd. pay dividends?
Nanollose Ltd. does not currently pay dividends.
What is Nanollose Ltd.’s EPS estimate?
Nanollose Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanollose Ltd. have?
Nanollose Ltd. has 409,026,920 shares outstanding.
What happened to Nanollose Ltd.’s price movement after its last earnings report?
Nanollose Ltd. reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.389%.
Which hedge fund is a major shareholder of Nanollose Ltd.?
Currently, no hedge funds are holding shares in AU:NC6
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanollose Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NC6 Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
188.88%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-23.63%
Trailing 12-Months
Company Description
Nanollose Ltd.
Nanollose Limited is an Australian biomaterials enterprise dedicated to the research, development, and commercialization of microbial nanocellulose technology. Its product line features Nullarbor Fibre, an innovative lyocell fibre produced without relying on trees, and Jelli Grow, an eco-friendly substitute for seed germination and cultivating plants. These materials find applications across various sectors, including textiles, nonwoven fabrics, and other industries. Established in 2014, the company's headquarters are situated in Nedlands, Australia.
Technical Analysis
Orthocell Ltd
―
Tissue Repair Ltd
―
AnteoTech Ltd
―
Avecho Biotechnology Limited
―
Botanix Pharmaceuticals Limited
―